HCN4-CatCh-IRES-lacZ Strain Information Sheet
Common Name: HCN4-CatCh-IRES-lacZ
CHROMusTM designation and lines available: R24:B17
Jackson Stock number: NA
Development: The rhodopsin based effector, CatCh was inserted at the ATG site of the HCN4 gene in the BAC RP23-281H22 (CHORI) through homologous recombination. The resulting recombinant BAC was injected into the male pronucleus of fertilized oocytes which were then implanted into pseudo pregnant females. Resulting offspring were screened for the presence of the transgene (founders). Colonies were established from each founder and tested for expression.
|# pups born||# founders||# expressers|
Description: The rhodopsin based effector, CatCh is expressed under control of the HCN4 promoter, directing expression to the SA node and the AV node of the heart and the nervous system (brain and spinal cord). Expression is observed in the developing 13.5 dpc heart. An internal ribosome entry site (IRES) allows for co-expression of lacZ as a visual indicator of expression patterns.
Additional data detailing CatCh activity will be added.
|Primer B107||GGA GAT CTA TGT GTG CGC TAT C|
|Primer B108||CCA GCA GTT CTT CGA CAT CA|
|Expected size of product:||535bp|
94oC 3 minutes
Acknowledgement: Please inform us of any publications resulting from the use of this mouse and use the following statement to acknowledge their development:
“The mouse strain HCN4-CatCh-IRES-lacZ was developed by CHROMusTM; funded by NIH R24HL120847.”